Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Therapeutic Drug Monitoring|May 27, 2003
Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipientsRandeep Mandla, Pål-Dag Line, Karsten Midtvedt, et al.
Therapeutic Drug Monitoring|September 23, 2008
Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individualsNils Tore Vethe, Sara Bremer, Helge Rootwelt, et al.
International Immunopharmacology|November 18, 2008
Expression of IMPDH1 is regulated in response to mycophenolate concentrationSara Bremer, Nils T Vethe, Helge Rootwelt, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 22, 2011
[Drug interactions and immunosuppression in organ transplant recipients]Nils Tore Vethe, Karsten Midtvedt, Anders Asberg, et al.
Therapeutic Drug Monitoring|November 19, 2024
Implementation of Volumetric Finger-Prick Self-Sampling for Therapeutic Drug Monitoring of Immunosuppressants After Kidney Transplantation: Lessons Learned From the PracticeNils Tore Vethe, Anders Åsberg, Stein Bergan, et al.
Therapeutic Drug Monitoring|January 8, 2015
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative ConditioningSara Bremer, Yngvar Fløisand, Lorentz Brinch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2005
Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipientsRandeep Mandla, Karsten Midtvedt, Pål-Dag Line, et al.
Therapeutic Drug Monitoring|January 12, 2019
A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass SpectrometryNils Tore Vethe, John Munkhaugen, Anders M Andersen, et al.
British Journal of Clinical Pharmacology|February 2, 2017
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantationElisabet Størset, Kristine Hole, Karsten Midtvedt, et al.
Transplantation|March 28, 2017
Exposure to Mycophenolate and FatherhoodKarsten Midtvedt, Stein Bergan, Anna Varberg Reisæter, et al.
Pageof 9